Agena Bioscience
Agena Bioscience is dedicated to empowering research laboratories worldwide with scalable targeted genomic data and delivering timely molecular insights. They offer innovative platforms like the MassARRAY System, which provides broad genetic coverage, rapid processing, and clear data analysis for various research applications including pharmacogenetics, mutation profiling, liquid biopsy, and hereditary genetics. With headquarters in San Diego, California, and a presence in over 30 countries, Agena Bioscience is a subsidiary of Mesa Labs, Inc. The company focuses on creating customer-centric solutions and advancing molecular diagnostics and research.
Industries
Nr. of Employees
medium (51-250)
Agena Bioscience
San Diego, California, United States, North America
Products
Benchtop multiplex mass spectrometry genetic analyzer (research)
Research-grade multiplex genetic analyzer that uses MALDI-TOF mass spectrometry and multiplex PCR chemistries for targeted genotyping, somatic mutation detection and quantitative analysis across a single platform.
Clinical-compatible benchtop multiplex genetic analyzer (CE‑IVD)
Clinical-grade analyzer option marketed with CE‑IVD availability to support targeted patient diagnostics, turn-around-time optimization and clinical workflows for marker-based testing.
Targeted pharmacogenetics panel (guideline-aligned content)
Targeted pharmacogenetics panel that covers a set of pharmacogenes and variants recommended by professional societies to provide genotype information for drug metabolism interpretation.
Liquid biopsy targeted panels for cfDNA variant detection
Targeted liquid biopsy panels and chemistries designed to detect somatic variants, including indels, from circulating cell-free DNA for oncology research applications.
Benchtop multiplex mass spectrometry genetic analyzer (research)
Research-grade multiplex genetic analyzer that uses MALDI-TOF mass spectrometry and multiplex PCR chemistries for targeted genotyping, somatic mutation detection and quantitative analysis across a single platform.
Clinical-compatible benchtop multiplex genetic analyzer (CE‑IVD)
Clinical-grade analyzer option marketed with CE‑IVD availability to support targeted patient diagnostics, turn-around-time optimization and clinical workflows for marker-based testing.
Targeted pharmacogenetics panel (guideline-aligned content)
Targeted pharmacogenetics panel that covers a set of pharmacogenes and variants recommended by professional societies to provide genotype information for drug metabolism interpretation.
Liquid biopsy targeted panels for cfDNA variant detection
Targeted liquid biopsy panels and chemistries designed to detect somatic variants, including indels, from circulating cell-free DNA for oncology research applications.
Services
Custom assay design and optimization
Design and optimization of custom targeted assays for research use, covering SNPs/INDELs, translocations, copy number variants and methylation markers for use on the mass spectrometry platform.
Certified service provider network and technical support
Access to a global network of certified service providers, regional support contacts, service plans and a customer support portal for training, maintenance and troubleshooting.
Custom assay design and optimization
Design and optimization of custom targeted assays for research use, covering SNPs/INDELs, translocations, copy number variants and methylation markers for use on the mass spectrometry platform.
Certified service provider network and technical support
Access to a global network of certified service providers, regional support contacts, service plans and a customer support portal for training, maintenance and troubleshooting.
Expertise Areas
- Pharmacogenetics (targeted PGx panel design and genotyping)
- Liquid biopsy and cfDNA variant detection
- Targeted mutation profiling for oncology
- Hereditary genetics testing workflows
Key Technologies
- MALDI-TOF mass spectrometry
- Multiplex end-point PCR with single-base extension
- Targeted panel assay design
- cfDNA (liquid biopsy) targeted detection